MARIOTTI, MATTEO
MARIOTTI, MATTEO
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial
2021 Livi L.; Barletta G.; Martella F.; Saieva C.; Desideri I.; Bacci C.; Del Bene M.R.; Airoldi M.; Amoroso D.; Coltelli L.; Scotti V.; Becherini C.; Visani L.; Salvestrini V.; Mariotti M.; Pedani F.; Bernini M.; Sanchez L.; Orzalesi L.; Nori J.; Bianchi S.; Olivotto I.; Meattini I.
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study
2020 Meattini, Icro; Poortmans, Philip; Kirova, Youlia; Saieva, Calogero; Visani, Luca; Salvestrini, Viola; Kim, Jiyoung; Jung, Wonguen; Olmetto, Emanuela; Mariotti, Matteo; Desideri, Isacco; Fourquet, Alain; Livi, Lorenzo; Kim, Kyubo
In reply to Egger et al.: Lack of benefit from adjuvant postoperative radiotherapy and issues raised about upfront management of high- and very-high-risk prostate cancer patients
2020 GIULIO FRANCOLINI, BEATRICE DETTI, MATTEO MARIOTTI, GABRIELLA NESI, GIANDOMENICO ROVIELLO, PIETRO SPATAFORA, ISACCO DESIDERI, DONATA VILLARI, LORENZO LIVI
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population
2021 Salvestrini V.; Mariotti M.; Banini M.; Becherini C.; Visani L.; Scotti V.; Desideri I.; Livi L.; Meattini I.
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases
2020 Desideri I.; Becherini C.; Visani L.; Stocchi G.; Scoccimarro E.; Mariotti M.; Salvestrini V.; Scoccianti S.; Greto D.; Bonomo P.; Pecchioli G.; Bordi L.; Della Puppa A.; Francolini G.; Meattini I.; Livi L.
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)
2021 Francolini G.; Loi M.; Salvestrini V.; Mangoni M.; Detti B.; Di Cataldo V.; Aquilano M.; Pinzani P.; Salvianti F.; Desideri I.; Mariotti M.; Garlatti P.; Stocchi G.; Ciccone L.P.; Lucidi S.; Salvatore G.; Sottili M.; Meattini I.; Livi L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial | 2021 | Livi L.; Barletta G.; Martella F.; Saieva C.; Desideri I.; Bacci C.; Del Bene M.R.; Airoldi M.; Amoroso D.; Coltelli L.; Scotti V.; Becherini C.; Visani L.; Salvestrini V.; Mariotti M.; Pedani F.; Bernini M.; Sanchez L.; Orzalesi L.; Nori J.; Bianchi S.; Olivotto I.; Meattini I. | |
| Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study | 2020 | Meattini, Icro; Poortmans, Philip; Kirova, Youlia; Saieva, Calogero; Visani, Luca; Salvestrini, Viola; Kim, Jiyoung; Jung, Wonguen; Olmetto, Emanuela; Mariotti, Matteo; Desideri, Isacco; Fourquet, Alain; Livi, Lorenzo; Kim, Kyubo | |
| In reply to Egger et al.: Lack of benefit from adjuvant postoperative radiotherapy and issues raised about upfront management of high- and very-high-risk prostate cancer patients | 2020 | GIULIO FRANCOLINI, BEATRICE DETTI, MATTEO MARIOTTI, GABRIELLA NESI, GIANDOMENICO ROVIELLO, PIETRO SPATAFORA, ISACCO DESIDERI, DONATA VILLARI, LORENZO LIVI | |
| Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population | 2021 | Salvestrini V.; Mariotti M.; Banini M.; Becherini C.; Visani L.; Scotti V.; Desideri I.; Livi L.; Meattini I. | |
| Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases | 2020 | Desideri I.; Becherini C.; Visani L.; Stocchi G.; Scoccimarro E.; Mariotti M.; Salvestrini V.; Scoccianti S.; Greto D.; Bonomo P.; Pecchioli G.; Bordi L.; Della Puppa A.; Francolini G.; Meattini I.; Livi L. | |
| Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) | 2021 | Francolini G.; Loi M.; Salvestrini V.; Mangoni M.; Detti B.; Di Cataldo V.; Aquilano M.; Pinzani P.; Salvianti F.; Desideri I.; Mariotti M.; Garlatti P.; Stocchi G.; Ciccone L.P.; Lucidi S.; Salvatore G.; Sottili M.; Meattini I.; Livi L. |